Airway Therapeutics scores $4.6 Million in Series A

Biotechnology company Airway Therapeutics has secured $4.6 million in Series A financing. CincyTech led the round, with participation from Cincinnati Children's Hospital Medical Center, Queen City Angels and private investors.

11 September 2014•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail